Functional assays further revealed that CSRNP1 knockdown enhanced HCC cell growth and invasiveness while suppressing apoptosis, with upregulation of Bcl-2 and reduced expression of cleaved caspase-3 and cleaved PARP1. This evidence concerns the gene BCL2 and hepatocellular carcinoma.